CombinedPEP® for Atelectasis
Setting 1, 2 or 3 creates CombinedPEP characterized as continuous positive pressure above baseline with applied pressure and flow changes. These settings maintain an appropriate positive expiratory pressure (PEP) that promotes collateral ventilation by stabilizing and enlarging the airways.
DynamicPEP® for Bronchial Secretions
Setting 4 or 5 creates DynamicPEP, erratic flow and pressure oscillations characterized by a slow increase from zero to Maximum with an abrupt return to zero. Viscous mucus cannot follow these fast movements which result in a shedding of mucous from the bronchial wall.
VibraPEP with non-mechanical, flow valve technology converts most of the patient effort into therapy. Requiring 34-54% LESS total lung volume than other OPEP devices. This allows patients to more easily achieve maximum therapeutic benefit from OPEP therapy.
Dual Therapy: Aerosol + OPEP
When clinically indicated, medication can be aerosolized and delivered to the peripheral airways in conjunction with OPEP therapy. The VibraPEP is FDA cleared for combined aerosol and OPEP therapy providing maximum therapeutic benefit. The patented one-way T-valve optimizes drug delivery enhancing the therapeutic benefit of combined therapy.